Matthew Strobeck
CIK 1377832 · last filed 2026-06-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$40.81M
Companies
5
Total Filings
88
Lifetime Open-Market Net
$11.83M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| QDEL | Director | 51,234 | $14.13 | $723.9K | $1.52M | 21 | 2026-06-02 |
| BDSX | Director | 2,661,931 | $15.06 | $40.09M | $6.89M | 18 | 2026-01-06 |
| Accelerate Diagnostics, Inc (AXDX) Delisted | Director | 323,238 | $0.03 | $11.0K | $2.67M | 24 | 2024-01-25 |
| YIELD10 BIOSCIENCE, INC. (MBLX) Delisted | Director | 66,664 | — | — | $752.6K | 23 | 2016-01-28 |
| SANTARUS INC (SNTS) Delisted | Director | — | — | — | $0 | 1 | 2012-05-16 |
Recent Filings · Page 4 of 9
88 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-11 | BDSX | Buy (P) | +1,117,318 | $2.00M | EDGAR |
| 2022-04-04 | BDSX | Exer (M) | +20,044 | $0 | EDGAR |
| 2022-01-04 | BDSX | Buy (P) | +147,800 | $642.9K | EDGAR |
| 2021-12-10 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | +19,531 | $150.0K | EDGAR |
| 2021-07-01 | BDSX | Grant (A) | — | $0 | EDGAR |
| 2021-05-24 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-20 | QDEL | Grant (A) | — | $0 | EDGAR |
| 2021-05-14 | QDEL | Exer (M) | +1,040 | $0 | EDGAR |
| 2021-04-13 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | +19,531 | $150.0K | EDGAR |
| 2021-02-24 | Accelerate Diagnostics, Inc (AXDX) Delisted | Grant (A) | +19,531 | $150.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.